Instil Bio, Inc. Key Metrics

2 years of history · ending 2021-12-31 · SEC EDGAR

Forensics

Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.

F-Score (Piotroski 0-9)

Z-Score (Altman; <1.81 = distress)

Per Share Metrics

Expense Ratios

Working Capital Analysis

Valuation Multiples

52-Week Range

ROIC vs WACC

Yields

Capital Deployment Yields

EPS (Diluted)
$-1
Book Value Per Share
$5
Free Cash Flow Per Share
$-2
Cash Per Share
$0
Revenue Per Share
$0
OCF Per Share
$-1
Return on Equity
-60.8%
Return on Assets
-33.8%
Return on Invested Capital
-47.7%
Current Ratio
11.22
Quick Ratio
11.22
Asset Turnover
0.00
R&D / Revenue
14057.2%
SBC / Revenue
1236.2%
Capex / Revenue
36823.2%
Working Capital
$423M
Net Current Asset Value
$409M
Invested Capital
$555M
OCF / Net Income
0.78
FCF / Net Income
1.15
Accruals Ratio (Sloan)
-5.7%
Net Debt
$-454M
Net Debt / EBITDA
2.97
Interest Coverage
Cash Coverage
Capex Coverage
-2.11
Tangible Common Equity
$549M
TCE / Total Assets
90.1%
Goodwill / Total Assets
0.9%
NOPAT
$-123M
Cash ROIC
-69.8%
WC / Revenue
168737.0%
Capex / D&A
21.01
Reinvestment Rate
-35.4%
Asset Growth vs Revenue Growth
191.2%
Stock Price (FY-end)
$342
Market Cap
$36.27B
P/B Ratio
65.33
P/TB Ratio
66.01
Enterprise Value
$35.82B
FCF Yield
-0.5%
Shareholder Yield
-0.1%
R&D Yield
0.3%
Capex Yield
0.2%
Shares Variation (YoY)
562.5%
Beta (5Y)
2.14
Cost of Equity
15.2%
52W High
$541
52W Low
$301
Trailing Return 1Y
F-Score (Piotroski)
1.00
Z-Score (Altman)
396.77

Earnings Forecasts

Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).

Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.

EPS — Consensus vs Actual

Stock Price on Earnings Dates